Janet Hammond MD PhD has worked for almost 20 years in the pharmaceutical industry where she has held positions of increasing responsibility. She was most recently head of Infectious Diseases at Hoffmann-la Roche for the past 5 years, where she has built and led their research and development efforts in the US, Switzerland and China, focusing on novel approaches for the treatment of Hepatitis B and Influenza. She also initiated the company’s re-entry into the area of antibiotic research and development.

Janet obtained her MD and PhD degrees from the University of Cape Town in South Africa, where she trained as an internist and specialized in pulmonary/ critical care medicine. She did her fellowship in Infectious Diseases at Duke and Johns Hopkins Universities before joining Glaxo SmithKline. She subsequently worked at Bristol Myers Squibb and Valeant and has been responsible for the development and approval of several new drugs both in the area of infectious disease and neuroscience.